AM24-MN-36-O: From Courts to Congress: Navigating the Healthcare Policy Landscape in 2024 (Enduring)

In today’s rapidly evolving healthcare environment, understanding the latest policy developments is crucial for strategic planning and operational success. This session will explore the significant implications of the recent Supreme Court decision – Loper Bright Enterprises v. Raimondo – which overturned a 40-year-old legal precedent that afforded federal agencies with significant discretion in interpreting the laws that they are charged with implementing. The landmark ruling may fundamentally change the way that Congress, Federal agencies, and the courts interact, and may have a substantial impact on healthcare policies. The session will dive into a case study of one issue that crosses Congress, Federal agencies and the courts. After years of Congressional efforts to regulate laboratory developed tests (LDTs), in 2024 the Food and Drug Administration (FDA) finalized a rule that regulates LDTs as medical devices. FDA is moving forward with implementing the final rule. However, two lawsuits have been filed that challenge the final rule, and some members of Congress remain interested in a legislative solution. This session will highlight one member’s experience leading efforts to shape public policies related to LDTs and will offer insights into preparing for the final rule to take effect. Attendees will have a greater understanding of the current health policy landscape, which will help them prepare for the future.